Bioavailability of Aspartic Acid Chelated Iron on Iron-deficient Rats

아스파르트산 킬레이트 철분의 철분 결핍쥐에서의 생물학적 유용성

  • Received : 2011.10.28
  • Accepted : 2011.11.23
  • Published : 2011.12.31


Aspartic acid chelated iron (Asp-Fe) was synthesized by a new method using calcium carbonate, aspartic acid, and ferrous sulfate. This study was carried out to investigate the bioavailability of Asp-Fe in iron-deficient rats. We divided the rats into four experimental groups. The first was the normal diet control group, or NC. The second was the no treated control group of iron-deficient (ID) rats, or ID+C. The third was the heme-iron (heme-Fe) treated group of ID rats, ID+heme-Fe. And the fourth was the Asp-Fe treated group of ID rats, or ID+Asp-Fe. There were no differences among any of the experimental groups in diet consumption, change of body weight, or the weight of the livers, kidneys, or spleens. After 7 days of feeding, the iron content in the sera of the ID+Asp-Fe group (175.2 ${\mu}g$/dL) and the ID+heme-Fe group (140.8 ${\mu}g$/dL) were significantly higher than that of the ID-C group (96.1 ${\mu}g$/dL). The total iron binding capacity (TIBC) of the ID+Asp-Fe group (735.4 ${\mu}g$/dL) was significantly normalized compared to the ID+C group (841.9 ${\mu}g$/dL) or ID+heme-Fe group (824.6 ${\mu}g$/dL). The hematocrit level of the ID+Asp-Fe group was increased to normal levels, but there was no statistical difference among ID groups. The absorption ratio of heme-Fe was 21.3% and that of Asp-Fe was 50.2%, which indicates a 2.3 times higher ratio in comparison with heme iron. With the above results we found that Asp-Fe seems to be an efficient form of iron to supply iron deficient rats in order to cure them of anemia. Thus, these findings suggest that aspartic acid chelated iron has the potential to serve as a functional food related to iron metabolism.


  1. Charlton RW, Bothwell TH. 1982. Definition, prevalence and prevention of iron deficiency. Clin Haematol 11: 309-325.
  2. Finch CA, Huebers H. 1982. Perspectives in iron metabolism. N Engl J Med 306: 1520-1528.
  3. Lieu PT, Heiskala M, Peterson PA, Yang Y. 2001. The roles of iron in health and disease. Mol Aspects Med 22: 1-87.
  4. Cairo G, Bernuzzi F, Recalcati S. 2006. A precious metal: Iron, an essential nutrient for all cells. Genes & Nutrition 1: 25-39.
  5. Beard JL. 2001. Iron biology in immune function, muscle metabolism and neuronal functioning. J Nutr 131: 568S-580S.
  6. Fritz JC, Pla GW, Roberts T, Boehne JW, Hove EL. 1970. Biological availability in animals of iron from common dietary sources. J Agric Food Chem 18: 647-651.
  7. Monsen ER. 1988. Iron nutrition and absorption-Dietary factors which impact iron bioavailability. J Am Diet Assoc 88: 786-790.
  8. Osterloh KRS, Simpson RJ, Snape S, Peters TJ. 1987. Intestinal iron-absorption and mucosal transferrin in rats subjected to hypoxia. Blut 55: 421-431.
  9. Mackenzie B, Garrick MD. 2005. Iron imports. II. Iron uptake at the apical membrane in the intestine. Am J Physiol Gastrointest Liver Physiol 289: G981-G986.
  10. Kim YJ. 1999. Iron bioavailability in iron-fortified market milk. J Korean Soc Food Sci Nutr 28: 705-709.
  11. Lebrun F, Bazus A, Dhulster P, Guillochon D. 1998. Solubility of heme in heme-iron enriched bovine hemoglobin hydrolysates. J Agric Food Chem 46: 5017-5025.
  12. The Korean Nutrition Society. 2010. Dietary reference intakes for Koreans. 8th rev. The Korean Nutrition Society, Seoul, Korea. p 409.
  13. Quintero-Gutierrez AG, González-Rosendo G, Sanchez-Munoz J, Polo-Pozo J, Rodríguez-Jerez JJ. 2008. Bioavailability of heme iron in biscuit filling using piglets as an animal model for humans. Int J Biol Sci 4: 58-62.
  14. Tako E, Rutzke MA, Glahn RP. 2010. Using the domestic chicken (Gallus gallus) as an in vivo model for iron bioavailability. Poult Sci 89: 514-521.
  15. Chen OS, Blemings KP, Schalinske KL, Eisenstein RS. 1998. Dietary iron intake rapidly influences iron regulatory proteins, ferritin subunits and mitochondrial aconitase in rat liver. J Nutr 128: 525-535.
  16. Kasvosve I, Delanghe J. 2002. Total iron binding capacity and transferrin concentration in the assessment of iron status. Clin Chem Lab Med 40: 1014-1018.
  17. Gottschalk R, Wigand R, Dietrich CF, Oremek G, Liebisch F, Hoelzer D, Kaltwasser JP. 2000. Total iron-binding capacity and serum transferrin determination under the influence of several clinical conditions. Clin Chim Acta 293: 127-138.
  18. Malin MJ, Mihalik MC, Sclafani L. 1983. Determination of hematocrit based on diffusion of an inert molecular probe from agarose gels into whole blood. Anal Biochem 129: 434-445.
  19. Miret S, Simpson RJ, McKie AT. 2003. Physiology and molecular biology of dietary iron absorption. Annu Rev Nutr 23: 283-301.
  20. Olivares M, Pizarro F, Pineda O, Name JJ, Hertrampf E, Walter T. 1997. Milk inhibits and ascorbic acid favors ferrous bis-glycine chelate bioavailability in humans. J Nutr 127: 1407-1411.
  21. Layrisse M, Garcia-Casal MN, Solano L, Baron MA, Arguello F, Llovera D, Ramirez J, Leets I, Tropper E. 2000. Iron bioavailability in humans from breakfasts enriched with iron bis-glycine chelate, phytates and polyphenols. J Nutr 130: 2195-2199.